Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Carcinoma, Squamous Cell × Paclitaxel × Clear all

Phase

Status

Sponsor Class

OTHER 20 INDUSTRY 5 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Esophageal Neoplasms 7 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 1 Recurrence 1 Nasopharyngeal Neoplasms 1 IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

Pemetrexed 1 Paclitaxel 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

ChineseAMS

Phase 1/2 Unknown

Adenocarcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡